Is teriparatide linked to osteosarcoma? A disproportionality analysis of the FAERS database. (PubMed, Pharmacol Rep) - Sep 18, 2026 - "This study highlights a disproportionate signal between teriparatide use and osteosarcoma when compared to all other drugs but not compared to romosozumab. Based on this and considering that previous evidence did not support an increased risk, further research is warranted to better understand this association."
Journal • Oncology • Osteoporosis • Osteosarcoma • Rheumatology • Sarcoma • Solid Tumor
|
|
Annalisa Capuano; Annamaria Mascolo; Concetta Rafaniello; Francesco Rossi; Liberata Sportiello; Ludovica Vittoria Laino; Nunzia Balzano; Raffaella Di Napoli; Rosanna Ruggiero
|